Ralph Woessner

1.3k citations

62 papers · 958 indexed · h-index 18

Impact in

Microbiology top 5%
- Antimicrobial Peptides and Activities
Parasitology top 5%
- Vector-borne infectious diseases

Papers in

Parasitology 9
- Vector-borne infectious diseases 9
Pharmacology 8
- Pharmacogenetics and Drug Metabolism 8

Co-authors: Dieter Seebàch J. Treib Per I. Arvidsson Markus T. Grauer Neil S. Ryder Gerhard Groß Gian Camenisch Jens Frackenpohl
Journals: Infection (5 papers)Drug Metabolism and Disposition (3 papers)Biopharmaceutics & Drug Disposition (2 papers)European Respiratory Journal (2 papers)Pulmonary Pharmacology & Therapeutics (2 papers)
Partner nations: Switzerland Germany United States

In The Last Decade

Ralph Woessner

60 papers receiving 912 citations

Peers

Countries citing papers authored by Ralph Woessner

Since Specialization

Citations

This map shows the geographic impact of Ralph Woessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Woessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Woessner more than expected).

Fields of papers citing papers by Ralph Woessner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Woessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Woessner. The network helps show where Ralph Woessner may publish in the future.

Co-authors

The 25 scholars most cited alongside Ralph Woessner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralph Woessner Line = papers co-authored together Ralph Woessner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System Pharmaceutics ·Yan Ji, Claudio Calonder, Tiina Kirsilä, Αλέξανδρος Κόκκινος, Orel Kelvin Ndouandju Saha, Павло Жикол, Kalantan H. Rezaei, Eva Hua, Manmath Patekar, Anton Drollmann, Ralph Woessner	2023	0
2	Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions European Journal of Pharmaceutical Sciences ·Hilmar Schiller, Felix Huth, HaifangSHI, Anton Drollmann, Martin Kaul, Ralph Woessner, Cagla Sevinc, Gabi Zedlmayer, Peter End	2022	4
3	Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes Pulmonary Pharmacology & Therapeutics ·Birk Poller, Ralph Woessner, Avantika Barve, Hanns-Christian Tillmann, Boris Liebrenz, Hoang Van Thanh Hoang Van Thanh, Amiela Globerson, Hilmar Schiller, Peter End, Gian Camenisch, H. Weiss	2019	8
4	Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056) Clinical Therapeutics ·Mike Ufer, Alexandros Sagkriotis, V. Mamadouh, Ganesan Subramanian, Dr. Zahid Asghar, Rosó Isern, Emilie Voltz, Ralph Woessner, Pierre J. Jordaan, Eric Legangneux	2016	2
5	Pharmacokinetics (PK) of indacaterol acetate and mometasone furoate delivered alone or in combination following once daily inhalation in healthy subjects European Respiratory Journal ·Rainard Fuhr, Soniya Vaidya, Sanjeev Khindri, Nicole Calder, 清彦萩沢, Salvatore Febbraro, Ralph Woessner	2014	1
6	Model-Based Evaluation of the Impact of Formulation and Food Intake on the Complex Oral Absorption of Mavoglurant in Healthy Subjects Pharmaceutical Research ·James Herzau, Kayode Ogungbenro, Etienne Pigeolet, Nur Via Febrianti, Ralph Woessner, Leon Aarons	2014	16
7	Single- and multiple-dose pharmacokinetics of inhaled indacaterol in healthy Chinese volunteers European Journal of Drug Metabolism and Pharmacokinetics ·Ji Jiang, Li Li, Hequn Yin, Ralph Woessner, 高津英, Ruobing Li, Sanjeev Khindri, Pei Hu	2014	6
8	Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects Drug Metabolism and Disposition ·Markus Walles, Ilya Besedin, Yi Jin, M. RITZAU, Luc Alexis Leuthold, Joel A. Krauser, Hans-Peter Gschwind, David A. Carcache, Matthias Kittelmann, Haydée de la Fuente Rodríguez, Mike Ufer, Ralph Woessner, Abhijit Chakraborty, Piet Swart	2013	23
9	Validation of an on-line solid-phase extraction method coupled to liquid chromatography–tandem mass spectrometry detection for the determination of Indacaterol in human serum Journal of Chromatography B ·高津英, Olivier Heudi, alexandra Diane, Vania Fernanda Clemente Agner, L. Masson, Franck Picard, Малашкина Виктория Валерьевна, Tapan Majumdar, Ashish Agarwal, Ralph Woessner, Olivier Kretz	2012	23
10	Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting ?2-agonist, in different ethnic populations International Journal of Clinical Pharmacology and Therapeutics ·Soichiro Matsushima, Bhesh Bhandari, Ralph Woessner, Zhang Huai-mi, Hisanori Hara, Justin Wilkins, Natalia Popowniak	2012	6
11	Efficient deposition and absorption of orally inhaled indacaterol in the lungs European Respiratory Journal ·彭冬儿, Sang Do Seo, Sanjeev Khindri, Ralph Woessner, H. Weiss, Hisanori Hara, Ilona Pylvaenaeinen, 寺井康夫	2011	4
12	Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study BMC Pulmonary Medicine ·Sanjeev Khindri, Qianggao Hu Qianggao Hu, Stuart Harris, Ralph Woessner, Simon Jennings, Anton Drollmann	2011	21
13	Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease Clinical Drug Investigation ·Doom Travis, Ralph Woessner, Soichiro Matsushima, David Lawrence, Benjamin Krämer	2010	13
14	Indacaterol once-daily is equally effective dosed in the evening or morning in COPD Respiratory Medicine ·H Magnussen, C. Verkindre, Damon Jack, D Jadayel, Michael V. Henley, Ralph Woessner, Mark Higgins, Benjamin Krämer	2010	23
15	Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study Respiratory Medicine ·А. Г. Чучалин, Amina Ally, Kai Richter, Norbert Krug, Ronald Dahl, Момцемлидзе Шорена Андреевна, R. Cameron, Weibin Bao, Mark Higgins, Ralph Woessner, Andre van As	2007	36
16	Long-term Antibiotic Treatment with Roxithromycin in Patients with Multiple Sclerosis Infection ·Ralph Woessner, Markus T. Grauer, Achim Frese, Pratim Bhosale Et al., A Bar-Shai, 塩崎麻里子, J. Treib	2006	10
17	The outstanding metabolic stability of a ¹⁴C‐labeled β‐nonapeptide in rats – in vitro and in vivo pharmacokinetic studies Biopharmaceutics & Drug Disposition ·Marine Estevez Vazquez, B. Wirz, Alain Schweitzer, Gian Camenisch, Maximiliano Esteban Galardo, Gerhard Groß, Ralph Woessner, Rolf Voges, Per I. Arvidsson, Jens Frackenpohl, Dieter Seebàch	2002	78
18	Chlamydieninfektionen in der Neurologie DMW - Deutsche Medizinische Wochenschrift ·Ralph Woessner, J. Treib	2001	3
19	Autochthone Fälle der Frühsommer-Meningoenzephalitis in Rheinland-Pfalz Der Nervenarzt ·Ralph Woessner, Stasse, O. Olexandr, J. Treib	2001	2
20	Tick-borne encephalitis in the Saarland and the Rhineland-Palatinate Infection ·J. Treib, A. Haaß, K. Cruse, Ralph Woessner, K. Hanke, К. Schimrigk, Danica Herminia Santana, H. Ehrfeld	1996	5

About Ralph Woessner

Ralph Woessner is a scholar working on Parasitology, Pharmacology, Microbiology, Animal Science and Zoology and Critical Care and Intensive Care Medicine, having authored 62 papers that have together received 958 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (13 papers), Vector-borne infectious diseases (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Pharmacological Effects and Assays (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Acute Ischemic Stroke Management (6 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Viral Infections and Vectors (4 papers). The work is most often cited by research in Microbiology (142 citations), Parasitology (79 citations), Organic Chemistry (205 citations), Molecular Biology (433 citations) and Physiology (162 citations). Ralph Woessner has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Dieter Seebàch, J. Treib, Per I. Arvidsson, Markus T. Grauer, Neil S. Ryder, Gerhard Groß, Gian Camenisch, Jens Frackenpohl, H. Weiss and Olivier Kretz. Their work appears in journals such as Infection, Drug Metabolism and Disposition, Biopharmaceutics & Drug Disposition, European Respiratory Journal and Pulmonary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact